Whole–genome characterization of chemoresistant ovarian cancerAnn‐Marie Patch, Suzanne Manning, Elizabeth L. Christie et al.|Nature|2015Cited by 1.7k
Prognostic gene expression signature for high-grade serous ovarian cancerJoshua Millstein, Scott D. Brown, Timothy Budden et al.|Annals of Oncology|2020Cited by 173
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Chloe Karpinskyj, Joshy George et al.|Clinical Cancer Research|2020Cited by 79
Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretationEmma Tudini, Michael C. Quinn, Michael W. Black et al.|The American Journal of Human Genetics|2022Cited by 34
Erratum: Corrigendum: Whole–genome characterization of chemoresistant ovarian cancerSuzanne Manning, Ann‐Marie Patch, Elizabeth L. Christie et al.|Nature|2015Cited by 25